ArticleScience advances2020

Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas.

Yuxiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.